OS Therapies OSTX
NYSE OSTX
$1.25 -0.01 (-1.18%)
As of: Oct 22, 2026 · 12:54 PM EDT

OS Therapies (OSTX) EPS (Basic) (2023 - 2026)

Updated

OS Therapies' EPS (Basic) came in at -$1.81 for Q2 2026, compared with -$0.95 a year earlier.

Analysis

OS Therapies (OSTX) EPS (Basic) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, OS Therapies reported EPS (Basic) of -$8.25; for FY2025, it was -$6.02.

  • Going back by year, EPS (Basic) was -$0.72 in FY2024 and -$1.46 in FY2023.
  • The five-year range for quarterly EPS (Basic) is -$2.82 (Q4 2025) to -$0.18 (Q3 2024).
  • Business Quant data shows OSTX's EPS (Basic) at -$2.18 (Q1 2026), -$2.82 (Q4 2025) and -$1.44 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn 7.95
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn 0.09
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn 2.04
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn -0.54
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn 1.68
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 1.62
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 4.40
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn -8.44
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn -0.04
10 OS Therapies 5.99 Mn 2.72 Mn - -1.81
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.81
Mar 31, 2026 -2.18
Dec 31, 2025 -2.82
Sep 30, 2025 -1.44
Jun 30, 2025 -0.95
Mar 31, 2025 -0.31
Dec 31, 2024 -0.24
Sep 30, 2024 -0.18
Jun 30, 2024 -0.26
Mar 31, 2024 -0.26
Dec 31, 2023 -0.28
Sep 30, 2023 -0.38
Jun 30, 2023 -0.47
Mar 31, 2023 -0.37
API Access

OS Therapies EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=OSTX&period=max&api_key=YOUR_API_KEY